我们名单上的下一只股票将是诺华。股票代码是NVS。在披露Pella Carson三期Horizon试验未达到主要终点后，该股下跌了12.77%。
The next stock on our list here is going to be Novartis. The ticker is NVS. It dropped 12.77% after it disclosed that the uh Pella Carson phase 3 Horizon trial did not meet its primary endpoint.
Selena问到了NVS，它有一些新闻。坦率地说，NVS最近没有太多好消息。诺华股价走低，此前该公司宣布Peloc Carson三期试验未达到主要终点。全球三期harbor研究评估Delerian在患有……
抱歉。>> 不，抱歉。我只是蜡烛图终于出现了。所以，我只是对下跌做出反应。>> 哦，明白了。好的。那么，让我继续讲新闻。抱歉。我不是故意让它分散我的注意力。嗯，在患有单基因营养不良症一型的人群中，未达到主要终点。
这里又有坏数据。13日的反应说明了一切。这次下跌使我们脱离了整个横盘区域。我的意思是，天哪，这可以追溯到三月，我们基本上甚至没有看一眼200日线。我们跌穿了20日、50日、100日和200日线。
我们大幅超跌。我们已经打破了我们所处的这个横盘结构。该股在这里下跌了13%。13。这怎么交易？
Selena asked for NVS which has some news here. Frankly, NVS not had a lot of good news recently. Novarta shares trading lower after the company announced that the uh Peloc Carson phase 3 trial did not meet its primary endpoint.
The global phase 3 harbor study evaluating Delerian and people living Sorry. >> No, sorry. I just the the candle finally showed up. So, I just was like reacting to the drop. >> Oh, gotcha.
Okay. So, let me keep going with the news here. Sorry. Didn't mean for that to distract me. Uh, in people living with um monic distrophe type one did not meet its primary endpoint.
More bad data here. 13th reaction tells the story. This drop takes us out of this entire sideways area. I mean, gosh, this goes back to March and we're basically we we did not even we did not even glance at the 200 day.
We went through the 20, 50, 100, and 200 day. We overshot it by a ton. We're we're we've broke this sideways structure that we're in. Stocks down 13% here. 13. What's the trade on this?
